Literature DB >> 26462987

Relative contribution of biological variation and technical variables to zone diameter variations of disc diffusion susceptibility testing.

Michael Hombach1, Carlos Ochoa2, Florian P Maurer3, Tamara Pfiffner3, Erik C Böttger3, Reinhard Furrer2.   

Abstract

OBJECTIVES: Disc diffusion is still largely based on manual procedures. Technical variations originate from inoculum preparation, variations in materials, individual operator plate streaking and reading accuracy. Resulting measurement imprecision contributes to categorization errors. Biological variation resembles the natural fluctuation of a measured parameter such as antibiotic susceptibility around a mean value. It is deemed to originate from factors such as genetic background or metabolic state. This study analysed the relative contribution of different technical and biological factors to total disc diffusion variation.
METHODS: For calculation of relative error factor contribution to disc diffusion variability, five experiments were designed keeping different combinations of error factors constant. A mathematical model was developed to analyse the individual error factor contribution to disc diffusion variation for each of the tested drug-species combinations.
RESULTS: The contribution of biological variation to total diameter variance ranged from 10.4% to 98.8% for different drug-species combinations. Highest biological variation was found for Enterococcus faecalis WT and vancomycin (98.8%) and for penicillinase-producing Staphylococcus aureus and penicillin G (96.0%). Average imprecision of automated zone reading revealed that 1.4%-5.3% of total imprecision was due to technical variation, while materials, i.e. antibiotic discs and agar plates, contributed between 2.6% and 3.9%. Inoculum preparation and manual plate streaking contributed 6.8%-24.8% and 6.6%-24.3%, respectively, to total imprecision.
CONCLUSIONS: This study illustrates the relative contributions of technical factors that account for a significant part of total variance in disc diffusion. The highest relative contribution originated from the operator, i.e. manual inoculum preparation and plate streaking. Further standardization of inoculum preparation and plate streaking by automation could potentially increase the precision of disc diffusion and improve the correlation of susceptibility reports with clinical outcome.
© The Author 2015. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26462987     DOI: 10.1093/jac/dkv309

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  9 in total

1.  A rapid, point-of-care antibiotic susceptibility test for urinary tract infections.

Authors:  Melody N Toosky; Jonathan T Grunwald; Daniela Pala; Byron Shen; Weian Zhao; Cartesio D'Agostini; Ferdinando Coghe; Giancarlo Angioni; Guido Motolese; Timothy J Abram; Eleonora Nicolai
Journal:  J Med Microbiol       Date:  2020-01       Impact factor: 2.472

2.  Standardization of Operator-Dependent Variables Affecting Precision and Accuracy of the Disk Diffusion Method for Antibiotic Susceptibility Testing.

Authors:  Michael Hombach; Florian P Maurer; Tamara Pfiffner; Erik C Böttger; Reinhard Furrer
Journal:  J Clin Microbiol       Date:  2015-10-14       Impact factor: 5.948

Review 3.  The Continued Value of Disk Diffusion for Assessing Antimicrobial Susceptibility in Clinical Laboratories: Report from the Clinical and Laboratory Standards Institute Methods Development and Standardization Working Group.

Authors:  Romney M Humphries; Susan Kircher; Andrea Ferrell; Kevin M Krause; Rianna Malherbe; Andre Hsiung; C A Burnham
Journal:  J Clin Microbiol       Date:  2018-07-26       Impact factor: 5.948

4.  Imipenem-Relebactam Susceptibility Testing of Gram-Negative Bacilli by Agar Dilution, Disk Diffusion, and Gradient Strip Methods Compared with Broth Microdilution.

Authors:  Hanna Hakvoort; Evelyn Bovenkamp; Kerryl E Greenwood-Quaintance; Suzannah M Schmidt-Malan; Jay N Mandrekar; Audrey N Schuetz; Robin Patel
Journal:  J Clin Microbiol       Date:  2020-09-22       Impact factor: 5.948

5.  Seeking patterns of antibiotic resistance in ATLAS, an open, raw MIC database with patient metadata.

Authors:  Pablo Catalán; Emily Wood; Jessica M A Blair; Ivana Gudelj; Jonathan R Iredell; Robert E Beardmore
Journal:  Nat Commun       Date:  2022-05-25       Impact factor: 17.694

6.  Wild-Type and Non-Wild-Type Mycobacterium tuberculosis MIC Distributions for the Novel Fluoroquinolone Antofloxacin Compared with Those for Ofloxacin, Levofloxacin, and Moxifloxacin.

Authors:  Xia Yu; Guirong Wang; Suting Chen; Guomei Wei; Yuanyuan Shang; Lingling Dong; Thomas Schön; Danesh Moradigaravand; Julian Parkhill; Sharon J Peacock; Claudio U Köser; Hairong Huang
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

7.  Insights into the Antimicrobial Activities and Metabolomes of Aquimarina (Flavobacteriaceae, Bacteroidetes) Species from the Rare Marine Biosphere.

Authors:  Sandra Godinho Silva; Patrícia Paula; José Paulo da Silva; Dalila Mil-Homens; Miguel Cacho Teixeira; Arsénio Mendes Fialho; Rodrigo Costa; Tina Keller-Costa
Journal:  Mar Drugs       Date:  2022-06-28       Impact factor: 6.085

8.  Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure-Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli.

Authors:  Johanna Seeger; Sebastian Guenther; Katharina Schaufler; Stefan E Heiden; Robin Michelet; Charlotte Kloft
Journal:  Antibiotics (Basel)       Date:  2021-05-21

Review 9.  Antimicrobial Susceptibility Testing of Antimicrobial Peptides to Better Predict Efficacy.

Authors:  Derry K Mercer; Marcelo D T Torres; Searle S Duay; Emma Lovie; Laura Simpson; Maren von Köckritz-Blickwede; Cesar de la Fuente-Nunez; Deborah A O'Neil; Alfredo M Angeles-Boza
Journal:  Front Cell Infect Microbiol       Date:  2020-07-07       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.